Healthcare -
Biotechnology - NASDAQ - US
$ 1.54
0 %
$ 4.63 M
Market Cap
-0.14
P/E
SONN - CASH & EQUIVALENTS
Cash & Equivalents SONN - Sonnet BioTherapeutics Holdings, Inc.
149 K
LAST VALUE
-77.87%
2 YEAR CAGR
33.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR